Skip to main content

BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Current Volume
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Partners
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Imaging
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Immunoassay signal amplification: bold new solutions for existing ELISAs REGISTER NOW!

Welcome to BioTechniques

1 MAY 2026 CANCER RESEARCH

New genetic discovery could spell this aggressive cancer’s downfall

30 APR 2026 DRUG DISCOVERY AND DEVELOPMENT

The A to V of m/z: recent updates in mass spectrometry for vaccine development

30 APR 2026 PCR AND SEQUENCING

eBook: The roles of endpoint, real-time and digital PCR in molecular research

30 APR 2026 MOLECULAR BIOLOGY

The biotech bi-weekly: a virtual biology initiative, a new discovery grant and a protein supplier to watch in cancer research in 2026

29 APR 2026 IMMUNOLOGY

Cold plasma could finally crack peanut allergies, making the nuts less allergenic

29 APR 2026 CAREERS AND PUBLISHING

Creating early career opportunities for advanced therapy manufacturing and development

1 / 6
7 APR 2026 CELL AND TISSUE BIOLOGY / ARTICLE

Uncovering the cellular origins of cancer and neurodevelopmental disease

29 APR 2026 CAREERS AND PUBLISHING / ARTICLE

Creating early career opportunities for advanced therapy manufacturing and development

2 APR 2026 MICROBIOLOGY / ARTICLE

Go with your gut: exploring the microbiota–gut–brain connection


Featured

23 APR 2026 SPOTLIGHT

Cell line development

17 MAR 2026 NEUROSCIENCE / PODCAST

The BRAIN miniseries | Exploring the neuropathogenesis of HIV and mentoring the next generation of scientists

19 FEB 2026 DIAGNOSTICS AND PRECLINICAL / PODCAST

The BRAIN miniseries | Investigating the link between vascular health and neurodegeneration in underrepresented populations

13 FEB 2026 NEUROSCIENCE / PODCAST

The BRAIN miniseries | Meet the neuroengineer building brain-monitoring devices and thriving communities

24 NOV 2025 IN FOCUS

New approach methodologies

13 NOV 2025 CAREERS AND PUBLISHING / PODCAST

STEM Tea | Humans first, professionals second

13 NOV 2025 IN FOCUS

Atomic force microscopy

21 OCT 2025 CAREERS AND PUBLISHING / PODCAST

STEM Tea | Investing in our students

Current Volume

29 JAN 2026 Reports / BioTechniques

A clinical biomarker assay to quantitate CXCL9 in human serum

29 JAN 2026 Reports / BioTechniques

Optimized Southern blotting for enhanced and precise detection of transgenes in CHO...

29 JAN 2026 Reports / BioTechniques

Optimization of proximity labeling in endothelial cells: overcoming endogenous biotin interference and...

29 JAN 2026 Benchmarks / BioTechniques

Benchmarking antibody discovery fidelity and reproducibility with an assay-locked residue fidelity index

Read Latest Issue Issue Archive Journal Archive JOURNAL ROUNDUP

Must Watch

26 MAR 2026 DIAGNOSTICS AND PRECLINICAL / WEBINAR

Immunoassay signal amplification: bold new solutions for existing ELISAs

24 FEB 2026 COMPUTATIONAL BIOLOGY / WEBINAR

Building databases to support clinical and research applications of long-read sequencing

4 FEB 2026 DRUG DISCOVERY AND DEVELOPMENT / WEBINAR

Webinar Q&A follow up: Antibodies to watch in 2026

2 JAN 2026 DRUG DISCOVERY AND DEVELOPMENT / WEBINAR

Antibodies to watch in 2026

24 NOV 2025 CELL AND TISSUE BIOLOGY / VIDEO

An introduction to new approach methodologies

13 NOV 2025 CELL AND TISSUE BIOLOGY / VIDEO

An introduction to atomic force microscopy

4 NOV 2025 WEBINAR / WEBINAR

How to sequence full-length 16S and ITS microbial amplicons

17 OCT 2025 CANCER RESEARCH / WEBINAR

Multiplex imaging and spatial analysis for biomarker-driven TME profiling

5 SEP 2025 CANCER RESEARCH / WEBINAR

Rapid epigenomic classification of acute leukemia

20 JUN 2025 DIAGNOSTICS AND PRECLINICAL / VIDEO

Autoimmune disease research solutions

What's Trending?

2 APR 2026 COMPUTATIONAL BIOLOGY / ARTICLE

Accelerating drug discovery with “paradigm shifting” AI model

10 APR 2026 CELL AND TISSUE BIOLOGY / ARTICLE

The most detailed map yet of the maternal–fetal connection

2 APR 2026 MICROBIOLOGY / ARTICLE

Go with your gut: exploring the microbiota–gut–brain connection

15 APR 2026 CELL AND TISSUE BIOLOGY / ARTICLE

Infographic: Comparing approaches to achieve monoclonal cell lines

8 APR 2026 CELL AND TISSUE BIOLOGY / ARTICLE

Controlling diabetes without insulin injections thanks to new implant

9 APR 2026 PCR AND SEQUENCING / ARTICLE

How long-read sequencing is scaling beyond the specialist lab

  • About BioTechniques
  • Advisory Board
  • Advertising
  • Permissions
  • Whitelist Emails
  • Press release policy
  • Accessibility
  • Editorial policies
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 BioTechniques